Cochrane seeks publishing partner from January 2021

Cochrane seeks publishing partner from January 2021

Cochrane, producer of the Cochrane Library, the world’s pre-eminent collection of high quality evidence to inform healthcare decisions, today announces the launch of a competitive tender to establish its future publishing partner from 2021 for the next decade.

Cochrane wants to identify a publishing partner that will increase the accessibility, awareness, impact and use of the Cochrane Library, and put Cochrane evidence at the heart of health decision-making globally; whilst also ensuring long-term financial sustainability of the organization, and innovation and development of other derivative products. Cochrane’s ‘Request for Proposal’ documents are available on request and proposals can be submitted up to 1 July 2019.

Cochrane’s Chief Executive Officer, Mark Wilson, welcomed launch of the tender: “This is a hugely exciting time for Cochrane. Over the past 25 years, Cochrane has transformed the way health decisions are made through the production and dissemination of our systematic reviews. But there are many challenges ahead including moves towards open access and open data publishing models, and the opportunities provided by new technology and machine-readable data to change the way we produce and deliver our content. I am confident that through this tender Cochrane will find the best publishing partner for these challenges: a partner who will help us get evidence into the hands of patients, clinicians and practitioners, researchers and policy-makers in ways that they can use it better.”

Cochrane Editor in Chief Elect, Karla Soares-Weiser, commented: “The Cochrane Library is pivotal in delivering Cochrane’s mission of producing high-quality, relevant, up-to-date systematic reviews and other synthesized research evidence to inform health decision making. Future publication and dissemination of our content are key to meeting Cochrane’s strategic goals and the long-term financial health of our global organization.”

Charlotte Pestridge, Head of Cochrane’s Innovations, Research & Development Department – and responsible for leading the competitive tender - said:We are now inviting proposals from suitable partners so that Cochrane can decide with whom, and under what terms, this unique and world-renowned product in the health and healthcare sector will be published in the future.”

Wednesday, May 22, 2019
Share/Save